Assertion: recurrent pericarditis | /r/HasProperty | corp
Facets:
Source sentences:
text: Colchicine for recurrent pericarditis (CORP): a randomized trial.
text: Colchicine for recurrent pericarditis (CORP): a randomized trial.
text: The 2015 ESC guidelines recommend colchicine for 6 months in recurrent pericarditis with level IA recommendation and is based on three important randomized trials including: COlchicine for REcurrent pericarditis (CORE), COlchicine for Recurrent Pericarditis (CORP) and efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2), once again orchestrated by Dr. Imazio and his team (see Table 2).